Literature DB >> 33922111

Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification.

Luigi Pannone1, Giulio Falasconi1, Lorenzo Cianfanelli1, Luca Baldetti1, Francesco Moroni1, Roberto Spoladore1, Pasquale Vergara2.   

Abstract

Sudden cardiac death (SCD) is the leading cause of cardiovascular mortality in patients with coronary artery disease without severe systolic dysfunction and in heart failure with preserved ejection fraction. From a global health perspective, while risk may be lower, the absolute number of SCDs in patients with left ventricle ejection fraction >35% is higher than in those with severely reduced left ventricle ejection fraction (defined as ≤35%). Despite these observations and the high amount of available data, to date there are no clear recommendations to reduce the sudden cardiac death burden in the population with mid-range or preserved left ventricle ejection fraction. Ongoing improvements in risk stratification based on electrophysiological and imaging techniques point towards a more precise identification of patients who would benefit from ICD implantation, which is still an unmet need in this subset of patients. The aim of this review is to provide a state-of-the-art approach in sudden cardiac death risk stratification of patients with mid-range and preserved left ventricular ejection fraction and one of the following etiologies: ischemic cardiomyopathy, heart failure, atrial fibrillation or myocarditis.

Entities:  

Keywords:  ICD; preserved ejection fraction; sudden cardiac arrest; sudden cardiac death

Year:  2021        PMID: 33922111     DOI: 10.3390/jcm10091823

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  102 in total

1.  Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?

Authors:  Konstantinos A Gatzoulis; Dimitris Tsiachris; Polichronis Dilaveris; Stefanos Archontakis; Petros Arsenos; Apostolis Vouliotis; Skevos Sideris; George Trantalis; Efstathios Kartsagoulis; Ioannis Kallikazaros; Christodoulos Stefanadis
Journal:  Int J Cardiol       Date:  2012-04-24       Impact factor: 4.164

2.  Change in Left Ventricular Ejection Fraction Following First Myocardial Infarction and Outcome.

Authors:  Derek S Chew; Huikuri Heikki; Georg Schmidt; Katherine M Kavanagh; Michael Dommasch; Poul Erik Bloch Thomsen; Daniel Sinnecker; Pekka Raatikainen; Derek V Exner
Journal:  JACC Clin Electrophysiol       Date:  2018-03-01

Review 3.  Atrial fibrillation and its association with sudden cardiac death.

Authors:  Lin Y Chen; David G Benditt; Alvaro Alonso
Journal:  Circ J       Date:  2014-09-26       Impact factor: 2.993

4.  Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.

Authors:  Abbasin Zegard; Osita Okafor; Joseph de Bono; Manish Kalla; Mauro Lencioni; Howard Marshall; Lucy Hudsmith; Tian Qiu; Richard Steeds; Berthold Stegemann; Francisco Leyva
Journal:  J Am Coll Cardiol       Date:  2021-01-05       Impact factor: 24.094

5.  C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study.

Authors:  Jean-Philippe Empana; Xavier Jouven; Florence Canouï-Poitrine; Gerald Luc; Muriel Tafflet; Bernadette Haas; Dominique Arveiler; Jean Ferrieres; Jean-Bernard Ruidavets; Michèle Montaye; John Yarnell; Pierre Morange; Frank Kee; Alun Evans; Philippe Amouyel; Pierre Ducimetiere
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-22       Impact factor: 8.311

6.  Sudden cardiac death in young people with apparently normal heart.

Authors:  D Corrado; C Basso; G Thiene
Journal:  Cardiovasc Res       Date:  2001-05       Impact factor: 10.787

7.  Pathogeneses of sudden cardiac death in national collegiate athletic association athletes.

Authors:  Kimberly G Harmon; Jonathan A Drezner; Joseph J Maleszewski; Martha Lopez-Anderson; David Owens; Jordan M Prutkin; Irfan M Asif; David Klossner; Michael J Ackerman
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-03-01

8.  Incidence and predictors of sudden cardiac death in patients with diastolic heart failure.

Authors:  Sana M Al-Khatib; Linda K Shaw; Christopher O'Connor; Melissa Kong; Robert M Califf
Journal:  J Cardiovasc Electrophysiol       Date:  2007-09-10

9.  Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.

Authors:  Peter M Okin; Casper N Bang; Kristian Wachtell; Darcy A Hille; Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-02-12

10.  Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study.

Authors:  Lin Y Chen; Nona Sotoodehnia; Petra Bůžková; Faye L Lopez; Laura M Yee; Susan R Heckbert; Ronald Prineas; Elsayed Z Soliman; Selcuk Adabag; Suma Konety; Aaron R Folsom; David Siscovick; Alvaro Alonso
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

View more
  2 in total

Review 1.  Risk factors of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Ying Hong; Wilber W Su; Xiaoping Li
Journal:  Curr Opin Cardiol       Date:  2022-01-01       Impact factor: 2.108

2.  Association of non-invasive electrocardiographic risk factors with left ventricular systolic function in post-myocardial infarction patients with mildly reduced or preserved ejection fraction: Insights from the PRESERVE-EF study.

Authors:  Konstantinos P Tsimos; Panagiotis Korantzopoulos; Petros Arsenos; Ioannis Doundoulakis; Dimitrios Tsiachris; Christos-Konstantinos Antoniou; Konstantinos Krikonis; Skevos Sideris; Polychronis Dilaveris; Konstantinos Triantafyllou; Stergios Soulaidopoulos; Emmanuel Kanoupakis; Nikolaos Fragakis; Antonios Sideris; Konstantinos Trachanas; Efstathios Iliodromitis; Dimitrios Tousoulis; Konstantinos Tsioufis; Theofilos M Kolettis; Konstantinos A Gatzoulis
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-07-06       Impact factor: 1.485

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.